Arama Sonuçları - Rimke Oostvogels
- Gösterilen 1 - 6 sonuçlar arası kayıtlar. 6
-
1
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor Yazar: Zsolt Sebestyén, Wouter Scheper, Anna Vyborova, Siyi Gu, Zuzana S. Rychnavska, Marleen Schiffler, Astrid Cleven, Coraline Chéneau, Martje van Noorden, Cassie-Marie Peigné, Daniel Olive, Robert Jan Lebbink, Rimke Oostvogels, Tuna Mutis, Gerrit Jan Schuurhuis, Erin J. Adams, Emmanuel Scotet, Jürgen Kuball
Baskı/Yayın Bilgisi 2016Artigo -
2
Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2–Restricted T Cell Epitopes Yazar: Rieuwert Hoppes, Rimke Oostvogels, Jolien J. Luimstra, Kim Wals, Mireille Toebes, Laura Bies, Reggy Ekkebus, Pramila Rijal, Patrick H. N. Celie, Julie H. Huang, Maarten E. Emmelot, Robbert M. Spaapen, Henk M. Lokhorst, Ton N. Schumacher, Tuna Mutis, Boris Rodenko, Huib Ovaa
Baskı/Yayın Bilgisi 2014Artigo -
3
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study Yazar: Mirian Brink, Frederik O. Meeuwes, Marjolein van der Poel, Marie José Kersten, Mariëlle J. Wondergem, Pim Mutsaers, Lara H. Böhmer, F. J. Sherida H. Woei‐A‐Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Wouter J. Plattel, Gerwin Huls, Joost S.P. Vermaat, Marcel Nijland
Baskı/Yayın Bilgisi 2022Artigo -
4
Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society COVID-19 Dataset Yazar: Ajai Chari, Mehmet Samur, Joaquín Martínez‐López, Gordon Cook, Noa Biran, Kwee Yong, Vânia Hungria, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva, Rimke Oostvogels, Alessandro Gozzetti, Cara A. Rosenbaum, Shaji Kumar, Edward A. Stadtmauer, Hermann Einsele, Meral Beksaç, Katja Weisel, Kenneth C. Anderson, María‐Victoria Mateos, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, Hervé Avet‐Loiseau
Baskı/Yayın Bilgisi 2020Pré-impressão -
5
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set Yazar: Ajai Chari, Mehmet Samur, Joaquín Martínez‐López, Gordon Cook, Noa Biran, Kwee Yong, Vânia Hungria, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva, Rimke Oostvogels, Alessandro Gozzetti, Cara A. Rosenbaum, Shaji Kumar, Edward A. Stadtmauer, Hermann Einsele, Meral Beksaç, Katja Weisel, Kenneth C. Anderson, María‐Victoria Mateos, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, Hervé Avet‐Loiseau
Baskı/Yayın Bilgisi 2020Artigo -
6
Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma Yazar: Inger S. Nijhof, Laurens E. Franssen, Mark‐David Levin, Gerard M.J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Paula F. Ypma, Reinier Raymakers, Dick-Johan van Spronsen, Peter E. Westerweel, Rimke Oostvogels, Jeroen van Velzen, Berris van Kessel, Tuna Mutis, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Niels W.C.J. van de Donk
Baskı/Yayın Bilgisi 2016Artigo
Arama Araçları:
İlgili Konular
Internal medicine
Medicine
Multiple myeloma
Biochemistry
Biology
Chemistry
Chemotherapy
Coronavirus disease 2019 (COVID-19)
Cyclophosphamide
Disease
Immunology
Infectious disease (medical specialty)
Prednisone
Virology
2019-20 coronavirus outbreak
Anaplastic large-cell lymphoma
Antigen
Autologous stem-cell transplantation
Bortezomib
CHOP
Cancer research
Cell
Cell biology
Comorbidity
Composite material
Cytoskeleton
Environmental health
Epitope
Etoposide
Gastroenterology